交易中 09-24 10:51:35 美东时间
-3.120
-3.66%
Aura Minerals (AUGO) said on Friday it entered into a $200M syndicated loan facility at its holding company level. The five-year loan carries interest at SOFR plus 2.70% annually and has a two-year gr...
09-18 20:44
今日重点评级关注:Canaccord Genuity:维持Generac Holdings"买入"评级,目标价从275美元升至375美元;巴克莱:维持Oscar Health"超配"评级,目标价从39美元升至49美元
09-18 16:18
Scotiabank analyst Alfonso Salazar initiates coverage on Aura Minerals (NASDAQ:AUGO) with a Sector Outperform rating and announces Price Target of $110.
09-17 21:50
Gold miners are suddenly behaving like a forgotten corner of the market that investors have rediscovered overnight. The VanEck Gold Miners ETF (NYSE:GDX) is up 23.75% in August. That would be its best month since April 2020, when it gained 40% in the first wave of pandemic stimulus. The fund changed...
08-18 04:18
Aura Minerals (NASDAQ:AUGO) reported quarterly earnings of $1.15 per share which missed the analyst consensus estimate of $1.23 by 6.5 percent. This is a 945.45 percent increase over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $335.967 million ...
08-06 05:25
Aura Minerals 2026财年第二季度净营收3.360亿美元,同比增长76%;净利润2.177亿美元,调整后EBITDA为1.967亿美元。金属价格和新增产能推动增长,但MSG改造令AISC升至1,985美元/GEO。
08-05 23:07
Aura Minerals Inc. announced a dividend of US$0.72 per common share, totaling approximately US$60.4 million, exceeding its Dividend Policy minimum. The dividend will be paid on August 28, 2026, to shareholders of record as of August 18, 2026. BDR holders will receive US$0.24 per BDR, equivalent to approximately BRL 1.217770 per BDR based on the exchange rate as of August 4, 2026, with payment expected around September 8, 2026. The company reporte...
08-05 21:28
今日重点评级关注:瑞杰金融:维持Electrovaya"强力买入"评级,目标价从14美元升至22美元;BTIG:维持vTv Therapeutics"买入"评级,目标价从49美元升至57美元
07-17 11:35
JP Morgan analyst Tathiane Candini maintains Aura Minerals (NASDAQ:AUGO) with a Overweight and lowers the price target from $104.5 to $91.
07-17 03:09
今日重点评级关注:HC Wainwright & Co.:维持Rockwell Medical"买入"评级,目标价从2美元升至20美元;Canaccord Genuity:维持创力"买入"评级,目标价从10.5美元升至11美元
07-10 17:36